Guided Therapeutics

    OverviewSuggest Edit

    Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices to enhance healthcare. Its technology, including products in research and development, primarily relates to biophotonics technology for the non-invasive detection of cancers. The company is developing LuViva, a non-invasive cervical cancer detection device; and extension of its cancer detection technology into other cancers, primarily esophageal. The company’s LuViva device would identify cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix.
    TypePublic
    Founded1992
    HQPeachtree Corners, US
    Websiteguidedinc.com

    Latest Updates

    Employees (est.) (Dec 2018)10

    Key People/Management at Guided Therapeutics

    Mark A. Samuels

    Mark A. Samuels

    CEO

    Guided Therapeutics Office Locations

    Guided Therapeutics has an office in Peachtree Corners
    Peachtree Corners, US (HQ)
    5835 Peachtree Corners E
    Show all (1)

    Guided Therapeutics Financials and Metrics

    Guided Therapeutics Revenue

    USD

    Net income (Q1, 2019)

    (215.0k)

    EBIT (Q1, 2019)

    (257.0k)

    Cash (31-Mar-2019)

    6.0k

    EV

    565.9k
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Cost of goods sold

    611.0k891.0k537.0k493.0k530.0k89.0k

    Sales and marketing expense

    901.0k1.2m718.0k393.0k245.0k195.0k

    General and administrative expense

    3.5m4.6m4.1m2.8m2.3m1.1m

    R&D expense

    2.7m2.8m1.5m733.0k334.0k244.0k
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

    Cost of goods sold

    117.0k192.0k271.0k260.0k107.0k207.0k230.0k68.0k33.0k85.0k16.0k82.0k97.0k3.0k1.0k1.0k

    Sales and marketing expense

    249.0k283.0k345.0k135.0k172.0k183.0k187.0k117.0k86.0k92.0k82.0k67.0k37.0k62.0k55.0k39.0k45.0k

    General and administrative expense

    822.0k1.1m999.0k1.4m963.0k1.0m1.1m917.0k760.0k510.0k346.0k382.0k1.2m246.0k381.0k154.0k182.0k

    R&D expense

    596.0k607.0k624.0k892.0k373.0k305.0k413.0k290.0k148.0k87.0k91.0k89.0k69.0k69.0k62.0k43.0k47.0k
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Cash

    613.0k162.0k35.0k14.0k1.0k

    Current Assets

    2.0m1.8m2.1m1.0m380.0k196.0k

    PP&E

    920.0k587.0k318.0k126.0k49.0k21.0k

    Total Assets

    3.3m3.0m2.6m1.5m489.0k236.0k
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

    Cash

    400.0k50.0k485.0k42.0k18.0k2.0m172.0k56.0k22.0k4.0k1.0k8.0k74.0k76.0k41.0k70.0k6.0k

    Accounts Receivable

    (89.0k)

    Inventories

    196.0k

    Current Assets

    1.5m1.5m1.9m2.1m1.6m3.3m2.3m2.0m2.1m1.9m1.1m1.1m830.0k466.0k368.0k447.0k167.0k
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Net Income

    (7.2m)(9.9m)(6.9m)(4.0m)(10.7m)1.0m

    Depreciation and Amortization

    461.0k1.1m1.2m213.0k27.0k

    Inventories

    (669.0k)61.0k345.0k508.0k151.0k

    Accounts Payable

    126.0k1.7m91.0k775.0k420.0k(6.0k)
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

    Net Income

    (5.0m)(1.6m)(3.7m)(6.7m)(1.2m)(3.0m)(5.1m)130.0k(1.7m)(211.0k)(107.0k)(1.2m)(3.5m)1.1m4.5m3.8m(215.0k)

    Depreciation and Amortization

    344.0k117.0k300.0k359.0k687.0k990.0k108.0k918.0k60.0k77.0k6.0k17.0k22.0k5.0k

    Inventories

    (296.0k)(61.0k)74.0k(11.0k)194.0k268.0k(135.0k)(120.0k)17.0k196.0k(30.0k)(14.0k)1.0k2.0k

    Accounts Payable

    57.0k377.0k172.0k774.0k1.6m231.0k(267.0k)153.0k384.0k2.5m2.7m288.0k366.0k(45.0k)(60.0k)(48.0k)(9.0k)
    USDY, 2019

    EV/EBIT

    -2.2 x

    EV/CFO

    -3 x
    Show all financial metrics

    Guided Therapeutics Online and Social Media Presence

    Embed Graph

    Guided Therapeutics News and Updates

    Pap Smear Hpv Testing Market players Johnson & Johnson, F. Hoffmann-La Roche Ltd., Guided Therapeutics, Inc.

    Cervical cancers are one of the leading causes of cancer deaths among women. Almost each type of cervical cancers is caused due to the infection by one of the 12 types of oncogenic human papilloma viruses (HPV). These HPV viruses are sexually transmitted and can cause most of the anal cancers; Poste…

    Guided Therapeutics Frequently Asked Questions

    • When was Guided Therapeutics founded?

      Guided Therapeutics was founded in 1992.

    • Who are Guided Therapeutics key executives?

      Guided Therapeutics's key executives are Mark A. Samuels.

    • How many employees does Guided Therapeutics have?

      Guided Therapeutics has 10 employees.

    • Who are Guided Therapeutics competitors?

      Competitors of Guided Therapeutics include Biocartis, Surefire Medical and Sensus Healthcare.

    • Where is Guided Therapeutics headquarters?

      Guided Therapeutics headquarters is located at 5835 Peachtree Corners E, Peachtree Corners.

    • Where are Guided Therapeutics offices?

      Guided Therapeutics has an office in Peachtree Corners.

    • How many offices does Guided Therapeutics have?

      Guided Therapeutics has 1 office.